Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.
Sci Rep 2018 May;8(1):8078
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.
Hum Vaccin Immunother 2017 12;13(12):2849-2858
Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.
AIDS Res. Hum. Retroviruses 2017 08;33(8):880-888
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.
Lancet Infect Dis 2015 Sep;15(9):1108-1114
Immunotherapy with an HIV-DNA Vaccine in Children and Adults.
Vaccines (Basel) 2014 Jul;2(3):563-80
Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.
AIDS Res. Hum. Retroviruses 2014 Mar;30(3):299-311